DNB – Supervisory Review and Evaluation Process (SREP) 2024

The Financial Supervisory Authority of Norway (“the FSA”) regularly carries out a Supervisory Review and Evaluation Process (“SREP”), where they

READ MORE

Cereno Scientific participates at DNB Nordic Healthcare Conference 2024

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for diseases with high unmet medical needs, today

READ MORE

DNB Bank ASA – status of share buy-back programme after week 37 2024

On 17 June 2024, DNB Bank ASA (“DNB”) announced that the company has decided to initiate a share buy-back programme

READ MORE

DNB Bank ASA’s share buy-back programme has been completed

DNB Bank ASA (“DNB”) has completed the share buy-back programme announced on 17 June 2024. A total of 9,850,699 shares,

READ MORE